Discontinued — last reported Q3 '22
Labcorp Holdings LabCorp Diagnostics — Operating Income (Loss) decreased by 16.9% to $378.70M in Q3 2022 compared to the prior quarter. Year-over-year, this metric declined by 47.6%, from $722.70M to $378.70M. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase signals improved operational efficiency, better cost management, or higher margins on diagnostic services.
This metric measures the profitability of the diagnostics segment after deducting operating expenses such as labor, supp...
Standard operating profit metric used across the healthcare services industry to benchmark segment performance.
lh_segment_labcorp_diagnostics_operating_income_loss| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | |
|---|---|---|---|---|---|
| Value | $603.60M | $722.70M | $623.30M | $455.50M | $378.70M |
| QoQ Change | — | +19.7% | -13.8% | -26.9% | -16.9% |
| YoY Change | — | — | — | -24.5% | -47.6% |